Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study

Intensive Care Med. 2020 Sep;46(9):1772-1773. doi: 10.1007/s00134-020-06142-y. Epub 2020 Jun 8.
No abstract available

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Acute Kidney Injury / epidemiology
  • Aged
  • Betacoronavirus
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / epidemiology*
  • Creatinine / blood
  • Critical Illness
  • Dose-Response Relationship, Drug
  • Drug Monitoring
  • Female
  • Half-Life
  • Humans
  • Hydroxychloroquine / pharmacokinetics*
  • Hydroxychloroquine / therapeutic use*
  • Intensive Care Units
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / epidemiology*
  • SARS-CoV-2

Substances

  • Hydroxychloroquine
  • Creatinine